Literature review to assemble the evidence for response scales used in patient-reported outcome measures View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-09-06

AUTHORS

Katharine Gries, Pamela Berry, Magdalena Harrington, Mabel Crescioni, Mira Patel, Katja Rudell, Shima Safikhani, Sheryl Pease, Margaret Vernon

ABSTRACT

Background: In the development of patient-reported outcome (PRO) instruments, little documentation is provided on the justification of response scale selection. The selection of response scales is often based on the developers' preferences or therapeutic area conventions. The purpose of this literature review was to assemble evidence on the selection of response scale types, in PRO instruments. The literature search was conducted in EMBASE, MEDLINE, and PsycINFO databases. Secondary search was conducted on supplementary sources including reference lists of key articles, websites for major PRO-related working groups and consortia, and conference abstracts. Evidence on the selection of verbal rating scale (VRS), numeric rating scale (NRS), and visual analogue scale (VAS) was collated based on pre-determined categories pertinent to the development of PRO instruments: reliability, validity, and responsiveness of PRO instruments, select therapeutic areas, and optimal number of response scale options. Results: A total of 6713 abstracts were reviewed; 186 full-text references included. There was a lack of consensus in the literature on the justification for response scale type based on the reliability, validity, and responsiveness of a PRO instrument. The type of response scale varied within the following therapeutic areas: asthma, cognition, depression, fatigue in rheumatoid arthritis, and oncology. The optimal number of response options depends on the construct, but quantitative evidence suggests that a 5-point or 6-point VRS was more informative and discriminative than fewer response options. Conclusions: The VRS, NRS, and VAS are acceptable response scale types in the development of PRO instruments. The empirical evidence on selection of response scales was inconsistent and, therefore, more empirical evidence needs to be generated. In the development of PRO instruments, it is important to consider the measurement properties and therapeutic area and provide justification for the selection of response scale type. More... »

PAGES

41

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s41687-018-0056-3

DOI

http://dx.doi.org/10.1186/s41687-018-0056-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1106810485

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30238086


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Janssen Global Services LLC, 700 US 202, Raritan Ave, Raritan, NJ 08869 USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Janssen Global Services LLC, 700 US 202, Raritan Ave, Raritan, NJ 08869 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gries", 
        "givenName": "Katharine", 
        "id": "sg:person.01074767120.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01074767120.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Janssen Global Services LLC, 700 US 202, Raritan Ave, Raritan, NJ 08869 USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Janssen Global Services LLC, 700 US 202, Raritan Ave, Raritan, NJ 08869 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Berry", 
        "givenName": "Pamela", 
        "id": "sg:person.01272747665.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272747665.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Shire Pharmaceuticals, 500 Shire Way, Lexington, MA 02421 USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Shire Pharmaceuticals, 500 Shire Way, Lexington, MA 02421 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Harrington", 
        "givenName": "Magdalena", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Critical Path Institute, Patient-Reported Outcome Consortium, 1730 E River Rd, Tucson, AZ 85718 USA", 
          "id": "http://www.grid.ac/institutes/grid.417621.7", 
          "name": [
            "Critical Path Institute, Patient-Reported Outcome Consortium, 1730 E River Rd, Tucson, AZ 85718 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Crescioni", 
        "givenName": "Mabel", 
        "id": "sg:person.0776377623.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0776377623.64"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Critical Path Institute, Patient-Reported Outcome Consortium, 1730 E River Rd, Tucson, AZ 85718 USA", 
          "id": "http://www.grid.ac/institutes/grid.417621.7", 
          "name": [
            "Critical Path Institute, Patient-Reported Outcome Consortium, 1730 E River Rd, Tucson, AZ 85718 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Patel", 
        "givenName": "Mira", 
        "id": "sg:person.010014711070.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010014711070.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Outcomes & Evidence, Global Health & Value, Pfizer Ltd, Tadworth, Surrey, UK", 
          "id": "http://www.grid.ac/institutes/grid.418566.8", 
          "name": [
            "Outcomes & Evidence, Global Health & Value, Pfizer Ltd, Tadworth, Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rudell", 
        "givenName": "Katja", 
        "id": "sg:person.01135456060.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135456060.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Evidera, 7101 Wisconsin Ave. Suite 1400, Bethesda, MD 20814 USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Evidera, 7101 Wisconsin Ave. Suite 1400, Bethesda, MD 20814 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Safikhani", 
        "givenName": "Shima", 
        "id": "sg:person.01037447417.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01037447417.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Pfizer Inc., NYC, NY USA", 
          "id": "http://www.grid.ac/institutes/grid.410513.2", 
          "name": [
            "Pfizer Inc., NYC, NY USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pease", 
        "givenName": "Sheryl", 
        "id": "sg:person.016366673132.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016366673132.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Evidera, 7101 Wisconsin Ave. Suite 1400, Bethesda, MD 20814 USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Evidera, 7101 Wisconsin Ave. Suite 1400, Bethesda, MD 20814 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vernon", 
        "givenName": "Margaret", 
        "id": "sg:person.01070334311.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070334311.87"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s10865-006-9053-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028852700", 
          "https://doi.org/10.1007/s10865-006-9053-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-244x-12-34", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043986445", 
          "https://doi.org/10.1186/1471-244x-12-34"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1472-6963-12-256", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021256067", 
          "https://doi.org/10.1186/1472-6963-12-256"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11920-013-0361-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025482063", 
          "https://doi.org/10.1007/s11920-013-0361-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s41687-018-0051-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106805113", 
          "https://doi.org/10.1186/s41687-018-0051-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11136-012-0322-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013566582", 
          "https://doi.org/10.1007/s11136-012-0322-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.2013.618", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039762843", 
          "https://doi.org/10.1038/bjc.2013.618"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2288-5-31", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021487145", 
          "https://doi.org/10.1186/1471-2288-5-31"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11916-007-0201-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035339623", 
          "https://doi.org/10.1007/s11916-007-0201-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s41687-018-0053-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106807532", 
          "https://doi.org/10.1186/s41687-018-0053-6"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-09-06", 
    "datePublishedReg": "2018-09-06", 
    "description": "Background: In the development of patient-reported outcome (PRO) instruments, little documentation is provided on the justification of response scale selection. The selection of response scales is often based on the developers' preferences or therapeutic area conventions. The purpose of this literature review was to assemble evidence on the selection of response scale types, in PRO instruments. The literature search was conducted in EMBASE, MEDLINE, and PsycINFO databases. Secondary search was conducted on supplementary sources including reference lists of key articles, websites for major PRO-related working groups and consortia, and conference abstracts. Evidence on the selection of verbal rating scale (VRS), numeric rating scale (NRS), and visual analogue scale (VAS) was collated based on pre-determined categories pertinent to the development of PRO instruments: reliability, validity, and responsiveness of PRO instruments, select therapeutic areas, and optimal number of response scale options.\nResults: A total of 6713 abstracts were reviewed; 186 full-text references included. There was a lack of consensus in the literature on the justification for response scale type based on the reliability, validity, and responsiveness of a PRO instrument. The type of response scale varied within the following therapeutic areas: asthma, cognition, depression, fatigue in rheumatoid arthritis, and oncology. The optimal number of response options depends on the construct, but quantitative evidence suggests that a 5-point or 6-point VRS was more informative and discriminative than fewer response options.\nConclusions: The VRS, NRS, and VAS are acceptable response scale types in the development of PRO instruments. The empirical evidence on selection of response scales was inconsistent and, therefore, more empirical evidence needs to be generated. In the development of PRO instruments, it is important to consider the measurement properties and therapeutic area and provide justification for the selection of response scale type.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s41687-018-0056-3", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.3802992", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1290444", 
        "issn": [
          "2509-8020"
        ], 
        "name": "Journal of Patient-Reported Outcomes", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "2"
      }
    ], 
    "keywords": [
      "verbal rating scale", 
      "numeric rating scale", 
      "visual analog scale", 
      "PRO instruments", 
      "therapeutic areas", 
      "patient-reported outcome measures", 
      "Rating Scale", 
      "patient-reported outcome instruments", 
      "full-text references", 
      "rheumatoid arthritis", 
      "analog scale", 
      "outcome instruments", 
      "outcome measures", 
      "conference abstracts", 
      "reference lists", 
      "response scale", 
      "literature review", 
      "PsycINFO databases", 
      "literature search", 
      "lack of consensus", 
      "secondary search", 
      "measurement properties", 
      "key articles", 
      "response options", 
      "responsiveness", 
      "options", 
      "little documentation", 
      "evidence", 
      "asthma", 
      "arthritis", 
      "EMBASE", 
      "review", 
      "MEDLINE", 
      "pre-determined categories", 
      "oncology", 
      "depression", 
      "total", 
      "response scale options", 
      "group", 
      "development", 
      "fatigue", 
      "search", 
      "types", 
      "quantitative evidence", 
      "scale", 
      "instrument", 
      "consensus", 
      "database", 
      "area", 
      "supplementary source", 
      "number", 
      "cognition", 
      "measures", 
      "lack", 
      "validity", 
      "documentation", 
      "scale options", 
      "selection", 
      "purpose", 
      "preferences", 
      "categories", 
      "literature", 
      "list", 
      "Abstract", 
      "consortium", 
      "reliability", 
      "constructs", 
      "websites", 
      "reference", 
      "article", 
      "empirical evidence", 
      "justification", 
      "source", 
      "optimal number", 
      "properties", 
      "scale type", 
      "Convention", 
      "scale selection", 
      "developers\u2019 preferences", 
      "response scale selection", 
      "therapeutic area conventions", 
      "area conventions", 
      "response scale types", 
      "acceptable response scale types"
    ], 
    "name": "Literature review to assemble the evidence for response scales used in patient-reported outcome measures", 
    "pagination": "41", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1106810485"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s41687-018-0056-3"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30238086"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s41687-018-0056-3", 
      "https://app.dimensions.ai/details/publication/pub.1106810485"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:42", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_793.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s41687-018-0056-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s41687-018-0056-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s41687-018-0056-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s41687-018-0056-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s41687-018-0056-3'


 

This table displays all metadata directly associated to this object as RDF triples.

255 TRIPLES      22 PREDICATES      119 URIs      101 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s41687-018-0056-3 schema:about anzsrc-for:11
2 anzsrc-for:1117
3 schema:author Nb9827f5476c54f958330d681732523b5
4 schema:citation sg:pub.10.1007/s10865-006-9053-8
5 sg:pub.10.1007/s11136-012-0322-4
6 sg:pub.10.1007/s11916-007-0201-9
7 sg:pub.10.1007/s11920-013-0361-8
8 sg:pub.10.1038/bjc.2013.618
9 sg:pub.10.1186/1471-2288-5-31
10 sg:pub.10.1186/1471-244x-12-34
11 sg:pub.10.1186/1472-6963-12-256
12 sg:pub.10.1186/s41687-018-0051-8
13 sg:pub.10.1186/s41687-018-0053-6
14 schema:datePublished 2018-09-06
15 schema:datePublishedReg 2018-09-06
16 schema:description Background: In the development of patient-reported outcome (PRO) instruments, little documentation is provided on the justification of response scale selection. The selection of response scales is often based on the developers' preferences or therapeutic area conventions. The purpose of this literature review was to assemble evidence on the selection of response scale types, in PRO instruments. The literature search was conducted in EMBASE, MEDLINE, and PsycINFO databases. Secondary search was conducted on supplementary sources including reference lists of key articles, websites for major PRO-related working groups and consortia, and conference abstracts. Evidence on the selection of verbal rating scale (VRS), numeric rating scale (NRS), and visual analogue scale (VAS) was collated based on pre-determined categories pertinent to the development of PRO instruments: reliability, validity, and responsiveness of PRO instruments, select therapeutic areas, and optimal number of response scale options. Results: A total of 6713 abstracts were reviewed; 186 full-text references included. There was a lack of consensus in the literature on the justification for response scale type based on the reliability, validity, and responsiveness of a PRO instrument. The type of response scale varied within the following therapeutic areas: asthma, cognition, depression, fatigue in rheumatoid arthritis, and oncology. The optimal number of response options depends on the construct, but quantitative evidence suggests that a 5-point or 6-point VRS was more informative and discriminative than fewer response options. Conclusions: The VRS, NRS, and VAS are acceptable response scale types in the development of PRO instruments. The empirical evidence on selection of response scales was inconsistent and, therefore, more empirical evidence needs to be generated. In the development of PRO instruments, it is important to consider the measurement properties and therapeutic area and provide justification for the selection of response scale type.
17 schema:genre article
18 schema:inLanguage en
19 schema:isAccessibleForFree true
20 schema:isPartOf N32df65baec0c450bad09c384e02713d6
21 Nea4a7338c3f74f8b9ec397481ce44fc8
22 sg:journal.1290444
23 schema:keywords Abstract
24 Convention
25 EMBASE
26 MEDLINE
27 PRO instruments
28 PsycINFO databases
29 Rating Scale
30 acceptable response scale types
31 analog scale
32 area
33 area conventions
34 arthritis
35 article
36 asthma
37 categories
38 cognition
39 conference abstracts
40 consensus
41 consortium
42 constructs
43 database
44 depression
45 developers’ preferences
46 development
47 documentation
48 empirical evidence
49 evidence
50 fatigue
51 full-text references
52 group
53 instrument
54 justification
55 key articles
56 lack
57 lack of consensus
58 list
59 literature
60 literature review
61 literature search
62 little documentation
63 measurement properties
64 measures
65 number
66 numeric rating scale
67 oncology
68 optimal number
69 options
70 outcome instruments
71 outcome measures
72 patient-reported outcome instruments
73 patient-reported outcome measures
74 pre-determined categories
75 preferences
76 properties
77 purpose
78 quantitative evidence
79 reference
80 reference lists
81 reliability
82 response options
83 response scale
84 response scale options
85 response scale selection
86 response scale types
87 responsiveness
88 review
89 rheumatoid arthritis
90 scale
91 scale options
92 scale selection
93 scale type
94 search
95 secondary search
96 selection
97 source
98 supplementary source
99 therapeutic area conventions
100 therapeutic areas
101 total
102 types
103 validity
104 verbal rating scale
105 visual analog scale
106 websites
107 schema:name Literature review to assemble the evidence for response scales used in patient-reported outcome measures
108 schema:pagination 41
109 schema:productId N3942e56c036e435e90633710aca4675f
110 N6ee9f0b2e3c54a75aa45e7d3fcbd6781
111 Nafe7210925a3404fa26feab41254b634
112 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106810485
113 https://doi.org/10.1186/s41687-018-0056-3
114 schema:sdDatePublished 2021-12-01T19:42
115 schema:sdLicense https://scigraph.springernature.com/explorer/license/
116 schema:sdPublisher N4ae2161508e54de9bb6200c434d09c64
117 schema:url https://doi.org/10.1186/s41687-018-0056-3
118 sgo:license sg:explorer/license/
119 sgo:sdDataset articles
120 rdf:type schema:ScholarlyArticle
121 N017135ffcbfd467d86f69a0fb0446534 rdf:first sg:person.016366673132.52
122 rdf:rest N2d83285c60fe46e49422cd794cb39800
123 N2d83285c60fe46e49422cd794cb39800 rdf:first sg:person.01070334311.87
124 rdf:rest rdf:nil
125 N32df65baec0c450bad09c384e02713d6 schema:issueNumber 1
126 rdf:type schema:PublicationIssue
127 N3942e56c036e435e90633710aca4675f schema:name doi
128 schema:value 10.1186/s41687-018-0056-3
129 rdf:type schema:PropertyValue
130 N4ae2161508e54de9bb6200c434d09c64 schema:name Springer Nature - SN SciGraph project
131 rdf:type schema:Organization
132 N5ce428108d8e46578cb8320e37c5cc7a rdf:first sg:person.010014711070.16
133 rdf:rest Nf9ec99d902e94fe692017ba9ad01ebf3
134 N5d9203b24efc4354b888b47c8bca50d7 rdf:first sg:person.0776377623.64
135 rdf:rest N5ce428108d8e46578cb8320e37c5cc7a
136 N6eb1210a098e4f81b498a824261e71fa rdf:first Nf7a8820f61f846d1b07216e37324c5ce
137 rdf:rest N5d9203b24efc4354b888b47c8bca50d7
138 N6ee9f0b2e3c54a75aa45e7d3fcbd6781 schema:name pubmed_id
139 schema:value 30238086
140 rdf:type schema:PropertyValue
141 N719d09ce4fb4492ab0198bd273d3dae6 rdf:first sg:person.01037447417.42
142 rdf:rest N017135ffcbfd467d86f69a0fb0446534
143 Nafe7210925a3404fa26feab41254b634 schema:name dimensions_id
144 schema:value pub.1106810485
145 rdf:type schema:PropertyValue
146 Nb851872cf8e84a3caad9fbb922fe973b rdf:first sg:person.01272747665.42
147 rdf:rest N6eb1210a098e4f81b498a824261e71fa
148 Nb9827f5476c54f958330d681732523b5 rdf:first sg:person.01074767120.33
149 rdf:rest Nb851872cf8e84a3caad9fbb922fe973b
150 Nea4a7338c3f74f8b9ec397481ce44fc8 schema:volumeNumber 2
151 rdf:type schema:PublicationVolume
152 Nf7a8820f61f846d1b07216e37324c5ce schema:affiliation grid-institutes:None
153 schema:familyName Harrington
154 schema:givenName Magdalena
155 rdf:type schema:Person
156 Nf9ec99d902e94fe692017ba9ad01ebf3 rdf:first sg:person.01135456060.10
157 rdf:rest N719d09ce4fb4492ab0198bd273d3dae6
158 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
159 schema:name Medical and Health Sciences
160 rdf:type schema:DefinedTerm
161 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
162 schema:name Public Health and Health Services
163 rdf:type schema:DefinedTerm
164 sg:grant.3802992 http://pending.schema.org/fundedItem sg:pub.10.1186/s41687-018-0056-3
165 rdf:type schema:MonetaryGrant
166 sg:journal.1290444 schema:issn 2509-8020
167 schema:name Journal of Patient-Reported Outcomes
168 schema:publisher Springer Nature
169 rdf:type schema:Periodical
170 sg:person.010014711070.16 schema:affiliation grid-institutes:grid.417621.7
171 schema:familyName Patel
172 schema:givenName Mira
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010014711070.16
174 rdf:type schema:Person
175 sg:person.01037447417.42 schema:affiliation grid-institutes:None
176 schema:familyName Safikhani
177 schema:givenName Shima
178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01037447417.42
179 rdf:type schema:Person
180 sg:person.01070334311.87 schema:affiliation grid-institutes:None
181 schema:familyName Vernon
182 schema:givenName Margaret
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070334311.87
184 rdf:type schema:Person
185 sg:person.01074767120.33 schema:affiliation grid-institutes:None
186 schema:familyName Gries
187 schema:givenName Katharine
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01074767120.33
189 rdf:type schema:Person
190 sg:person.01135456060.10 schema:affiliation grid-institutes:grid.418566.8
191 schema:familyName Rudell
192 schema:givenName Katja
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135456060.10
194 rdf:type schema:Person
195 sg:person.01272747665.42 schema:affiliation grid-institutes:None
196 schema:familyName Berry
197 schema:givenName Pamela
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272747665.42
199 rdf:type schema:Person
200 sg:person.016366673132.52 schema:affiliation grid-institutes:grid.410513.2
201 schema:familyName Pease
202 schema:givenName Sheryl
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016366673132.52
204 rdf:type schema:Person
205 sg:person.0776377623.64 schema:affiliation grid-institutes:grid.417621.7
206 schema:familyName Crescioni
207 schema:givenName Mabel
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0776377623.64
209 rdf:type schema:Person
210 sg:pub.10.1007/s10865-006-9053-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028852700
211 https://doi.org/10.1007/s10865-006-9053-8
212 rdf:type schema:CreativeWork
213 sg:pub.10.1007/s11136-012-0322-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013566582
214 https://doi.org/10.1007/s11136-012-0322-4
215 rdf:type schema:CreativeWork
216 sg:pub.10.1007/s11916-007-0201-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035339623
217 https://doi.org/10.1007/s11916-007-0201-9
218 rdf:type schema:CreativeWork
219 sg:pub.10.1007/s11920-013-0361-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025482063
220 https://doi.org/10.1007/s11920-013-0361-8
221 rdf:type schema:CreativeWork
222 sg:pub.10.1038/bjc.2013.618 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039762843
223 https://doi.org/10.1038/bjc.2013.618
224 rdf:type schema:CreativeWork
225 sg:pub.10.1186/1471-2288-5-31 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021487145
226 https://doi.org/10.1186/1471-2288-5-31
227 rdf:type schema:CreativeWork
228 sg:pub.10.1186/1471-244x-12-34 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043986445
229 https://doi.org/10.1186/1471-244x-12-34
230 rdf:type schema:CreativeWork
231 sg:pub.10.1186/1472-6963-12-256 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021256067
232 https://doi.org/10.1186/1472-6963-12-256
233 rdf:type schema:CreativeWork
234 sg:pub.10.1186/s41687-018-0051-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106805113
235 https://doi.org/10.1186/s41687-018-0051-8
236 rdf:type schema:CreativeWork
237 sg:pub.10.1186/s41687-018-0053-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106807532
238 https://doi.org/10.1186/s41687-018-0053-6
239 rdf:type schema:CreativeWork
240 grid-institutes:None schema:alternateName Evidera, 7101 Wisconsin Ave. Suite 1400, Bethesda, MD 20814 USA
241 Janssen Global Services LLC, 700 US 202, Raritan Ave, Raritan, NJ 08869 USA
242 Shire Pharmaceuticals, 500 Shire Way, Lexington, MA 02421 USA
243 schema:name Evidera, 7101 Wisconsin Ave. Suite 1400, Bethesda, MD 20814 USA
244 Janssen Global Services LLC, 700 US 202, Raritan Ave, Raritan, NJ 08869 USA
245 Shire Pharmaceuticals, 500 Shire Way, Lexington, MA 02421 USA
246 rdf:type schema:Organization
247 grid-institutes:grid.410513.2 schema:alternateName Pfizer Inc., NYC, NY USA
248 schema:name Pfizer Inc., NYC, NY USA
249 rdf:type schema:Organization
250 grid-institutes:grid.417621.7 schema:alternateName Critical Path Institute, Patient-Reported Outcome Consortium, 1730 E River Rd, Tucson, AZ 85718 USA
251 schema:name Critical Path Institute, Patient-Reported Outcome Consortium, 1730 E River Rd, Tucson, AZ 85718 USA
252 rdf:type schema:Organization
253 grid-institutes:grid.418566.8 schema:alternateName Outcomes & Evidence, Global Health & Value, Pfizer Ltd, Tadworth, Surrey, UK
254 schema:name Outcomes & Evidence, Global Health & Value, Pfizer Ltd, Tadworth, Surrey, UK
255 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...